Surgeons raise concerns about Ozempic, other GLP-1s
Surgeons and health system leaders are voicing concerns about the unknown long-term risks of GLP-1 receptor agonists, such as Ozempic, Wegovy and Saxenda.
Source: beckershospitalreview.com
Christopherc Thompson News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Christopherc Thompson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Christopherc Thompson Today - Breaking & Trending Today
Ozempic sparks debate on surgery prep
Amid the minimal data, physicians have conflicting opinions about stopping GLP-1 regimens before surgeries. The American Society of Anesthesiologists and the American Gastroenterological Association weigh in.
Source: beckershospitalreview.com
GI Dynamics EndoBarrier meets endpoints in diabetes, obesity study
GI Dynamics today announced the results of a study of its EndoBarrier system that met efficacy and safety endpoints.
Source: massdevice.com